🦟 Dengue: A Global Health Challenge

Dengue is one of the most rapidly spreading mosquito-borne viral diseases in the world, transmitted primarily by the Aedes aegypti mosquito. It affects more than 400 million people annually, with nearly half of the global population at risk.

Low (0 - 10%) Moderate (10 - 30%) High (30 - 50+%)

💡 Our Mission at UDD

At Universal Drug Discovery (UDD), we are leveraging AI-driven drug design, molecular simulations, and quantum chemistry to accelerate the discovery of novel compounds targeting proteins of the Dengue virus, particularly those related to NS3 and NS5. Our approach combines:

• Computational screening of billions of compounds.

• In vitro assays for antiviral activity.

Our vision is to bridge the gap between computation and clinic, ultimately delivering effective therapies against Dengue.

Protein-ligand interaction analysis for the dengue NS5 inhibitor compound (Published in International Journal of Molecular Science)

The dengue NS5 inhibitor compounds inside the binding pocket (Published in International Journal of Molecular Science)

Rooted in Research. Proven in Peer-Reviewed Journals.